Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects

Fausto Almeida1, Julie M Wolf2, Thiago Aparecido da Silva3

  • 1Department of Biochemistry and Immunology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, 14049-900, Brazil.

Nature Communications
|December 8, 2017
PubMed

Insights

Galectin-3 (Gal-3) enhances immunity against Cryptococcus neoformans fungal infections. Gal-3 deficiency increases susceptibility, while Gal-3 inhibits fungal growth and destabilizes fungal extracellular vesicles, improving host outcomes.

Area of Science:

  • Immunology
  • Mycology
  • Infectious Diseases

Background:

  • Cryptococcus neoformans causes opportunistic infections in immunocompromised individuals.
  • Galectin-3 (Gal-3) is a mammalian protein modulating host immunity during microbial infections.

Purpose of the Study:

  • To investigate the role of Galectin-3 (Gal-3) in Cryptococcus neoformans infection.
  • To determine Gal-3's impact on host immune response and fungal pathogenesis.

Main Methods:

  • Measured Gal-3 serum and tissue levels in human and murine cryptococcosis models.
  • Assessed cryptococcosis severity in Gal-3-deficient mice compared to wild-type.
  • Performed in vitro studies on Gal-3's effect on C. neoformans growth and extracellular vesicles.

Main Results:

  • Elevated Gal-3 levels observed in serum and tissues during C. neoformans infection.
  • Gal-3-deficient mice exhibited increased fungal burden and reduced survival.
  • In vitro, Gal-3 inhibited fungal growth and lysed C. neoformans extracellular vesicles.

Conclusions:

  • Galectin-3 plays a direct role in antifungal immunity against C. neoformans.
  • Gal-3 limits fungal growth and destabilizes extracellular vesicles, contributing to host protection.

Related Concept Videos